We recommend an MRI frequency of at least every three months and no more than every six months, due to the risk of high-grade adenocarcinoma progressing into highly malignant and rapidly evolving atypical variants, rendering PSA tests ineffective. Here, KLK3 is linked to adenocarcinoma.